Isagenix Brain Boost & Renewal Improves Cognitive Functions in Middle-Aged Adults
If you thought declining cognitive functions was only a problem for the elderly, think again.
Recent research has shown that a decline in cognitive functions begins decades before symptoms actually appear. In fact, scientists have found progressive declines in memory, learning, attention, and decision-making in people as young as 35 years old (1).
Because of this looming threat, Michael Colgan, Ph. D., expert in brain aging, along with Isagenix scientists collaborated on finding a solution for preserving brain health. More than 1,000 animal studies and human clinical trials have identified a number of individual nutrients that support different aspects of brain function (2-7). One of the major findings gleaned from these studies was that a synergistic blend of nutrients multiplies the power to support brain function beyond the use of individual nutrients alone.
Unlike other companies who use only one or two individual nutrients to support one or two brain functions, Isagenix has sought the best synergistic combinations to support multiple brain structures and functions. Taking from the most significant research, the Isagenix team came up with three different formulas of synergistic combinations of eight nutrients. By testing three different formulations in a clinical pilot study, the team was able to assess which product showed the greatest improvements in various cognitive tests.
Thirty-eight subjects ages 35 and older received one of three developed brain products. All subjects were also given Product B, IsaOmega Supreme, and IsaLean Shakes. Baseline cognitive evaluation of the subjects consisted of tests designed to analyze:
- Balance: Determines the accuracy that the brain receives, interprets, and processes information from various systems that control balance.
- Brain speed: Analyzes how quickly the brain can process information and convert it into an action.
- Working memory: Assesses how well the brain can actively hold multiple pieces of information.
- Cognitive flexibility: Determines accuracy of hand-eye coordination.
After supplementation for 3 and 6 weeks, subjects returned for their cognitive re-evaluations.
In just six weeks, the Isagenix Brain Boost & Renewal formula showed improvement in brain fitness, especially in memory and cognitive flexibility, compared to the other formulations.
This comprehensive brain protecting formulation is designed to protect mitochondria (the powerhouses of our cells) from oxidative stress, combat cellular reactivity, slow glycation (sugar toxicity on the brain and a major cause of premature aging), stimulate growth of neurons, and boost neurotransmitter function. (For information on how each of the ingredients work, see our article “Superhero Nutrients for Your Aging Brain”.)
Through these mechanisms, Isagenix Brain Boost & Renewal helps maintain memory, promotes mental focus, concentration, and decision-making, and supports healthy brain aging.
“It’s never too early or late to start giving your brain everything it needs to build a long, healthy and sustained life,” states Colgan. “The best investment you will ever make is in the future health of your brain.”
Click Here to purchase. Use signup and save option for 25% off retail pricing (no ongoing commitments required)
- Singh-Manoux A, Kivimaki M, Glymour MM et al. Timing of onset of cognitive decline: results from Whitehall II prospective cohort study. BMJ 2012;344:d7622.
- Begum AN, Jones MR, Lim GP et al. Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer’s disease. J Pharmacol Exp Ther 2008;326:196-208.
- Bhardwaj RK, Glaeser H, Becquemont L, Klotz U, Gupta SK, Fromm MF. Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4. J Pharmacol Exp Ther 2002;302:645-50.
- Wattanathorn J, Chonpathompikunlert P, Muchimapura S, Priprem A, Tankamnerdthai O. Piperine, the potential functional food for mood and cognitive disorders. Food Chem Toxicol 2008;46:3106-10.
- Carlson DA, Smith AR, Fischer SJ, Young KL, Packer L. The plasma pharmacokinetics of R-(+)-lipoic acid administered as sodium R-(+)-lipoate to healthy human subjects. Altern Med Rev 2007;12:343-51.
- Montgomery SA, Thal LJ, Amrein R. Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer’s disease. Int Clin Psychopharmacol 2003;18:61-71.
- Arenth PM, Russell KC, Ricker JH, Zafonte RD. CDP-choline as a biological supplement during neurorecovery: a focused review. PM R 2011;3:S123-S131.